Motor Neurone Disease is a life-shortening disease affecting 1 in 300 people. There is no known cure.
The MND Translational Accelerator (MNDAcc) is a £6m investment by the Medical Research Council and the National Institute for Health and Care Research to quicken the development of treatments for MND, and the related condition of Frontotemporal dementia (FTD). MNDAcc is part of a national drive to translate new discoveries into treatments, providing infrastructure, facilities, services, and funding for high quality in-human research.
Speaking about the creation of the MND Translational Accelerator, Health and Social Care Secretary Steve Barclay said:
“Motor Neurone disease has a devastating impact on people’s lives. That is why I am cutting red tape to accelerate funding for cutting-edge research by leading scientists into finding a cure.
“This collaboration will help identify new potential treatments for MND – backed by £6 million of government investment as part of our pledged £50 million funding for MND research to help find a cure.
“I encourage researchers from a range of disciplines to join the scheme and harness the world-leading facilities available at Dementias Platform UK and UK Dementia Research Institute.”
Don't miss the funding application deadline
The closing date for submitting Expressions of Interest in funding and support from the MND Translational Accelerator is Friday 1st December.
All submissions outlining research projects need to be completed and uploaded for consideration by the end of the day on Friday 1st December 2023. Applicants will be notified on 15th December about the outcome. Those projects invited to submit full proposals will be asked to present them by 2nd February 2024.